Company: HFFG
Filing Date: 2025-04-07
Form Type: S-3/A
Source: 0001628280-25-016967
Chunk: 21

Company: HF Foods Group Inc.
Filing Date: 2025-04-07
Form: S-3/A
Chunk 21
---
 stockholders reserve the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of shares of our common stock to be made directly or through agents. We will not receive any of the proceeds from any offering by the selling stockholders.

The selling stockholders also may in the future resell a portion of our common stock in open market transactions in reliance upon Rule 144 under the Securities Act, provided that they meet the criteria and conform to the requirements of that rule, or pursuant to other available exemptions from the registration requirements of the Securities Act.

To the extent required, our common stock to be sold, the purchase prices and public offering prices, the names of any agent, dealer or underwriter, and any applicable discounts, commissions, concessions or other compensation with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus.

The selling stockholders may grant to the underwriters options to purchase additional securities to cover over-allotments, if any, at the public offering price, with additional underwriting commissions or discounts, as may be set forth in a related prospectus supplement. The terms of any over-allotment option will be set forth in the prospectus supplement for those securities.

If the selling stockholders use a dealer in the sale of the securities being offered pursuant to this prospectus or any prospectus supplement, the selling stockholders will sell the securities to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale. If required, the names of the dealers and the terms of the transaction will be specified in a prospectus supplement.

The selling stockholders may sell the securities directly or through agents they designated from time to time. If required, we will name any agent involved in the offering and sale of securities and we will describe any commissions paid to the agent in the applicable prospectus supplement.

We or the selling stockholders may authorize agents or underwriters to solicit offers by institutional investors to purchase securities from the selling stockholders at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. If required, we will describe the conditions to these contracts and the commissions we must pay for solicitation of these contracts in the prospectus supplement.

<div align='center'>17</div>

In connection